Skip to main content

Continuum Advisory, LLC

SEC CIK
0001846532
Latest filing
Aug 6, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Continuum Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
39
Value
$1.46K
% of portfolio
<0.1%
Quarters held
6
Since Q1 2024
Holdings of CRNX by Continuum Advisory, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202639$1.46K<0.1%+39NewHolders
Q2 20250$00.0%−25−100.0%Sold outHolders
Q1 202525$839<0.1%+1+4.2%AddedHolders
Q4 202424$1.23K<0.1%00.0%UnchangedHolders
Q3 202424$1.43K<0.1%+11+84.6%AddedHolders
Q2 202413$582<0.1%00.0%UnchangedHolders
Q1 202413$642<0.1%+13NewHolders